We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Novel High-Throughput Screen Focuses on Appetite Regulating Enzyme

By LabMedica International staff writers
Posted on 25 Nov 2010
A fluorescence-based assay method has been used as a high-throughput screen for drugs to inhibit the enzyme ghrelin O-acyltransferase (GOAT), which is critically linked to molecular pathways regulating appetite.

Ghrelin is a 28 amino acid, appetite-stimulating peptide hormone secreted by the food-deprived stomach. More...
Serine-3 of ghrelin is acylated with an eight-carbon fatty acid, octanoate, which is required for its endocrine actions.

GOAT is a membrane-bound enzyme that attaches octanoate to serine-3 of ghrelin. Analysis of the mouse genome has revealed that GOAT belongs to a family of 16 hydrophobic membrane-bound acyltransferases. GOAT is the only member of this family that octanoylates ghrelin when coexpressed in cultured endocrine cell lines with prepro-ghrelin. GOAT activity requires catalytic asparagine and histidine residues that are conserved in this family. Consistent with its function, GOAT mRNA is largely restricted to stomach and intestine, the major ghrelin-secreting tissues.

Investigators at the Scripps Research Institute (La Jolla, CA, USA) applied a novel fluorescence-based assay to the problem of assessing GOAT activity. The assay, which they called cat-ELCCA (catalytic assay using enzyme-linked click chemistry assay), associates "click chemistry” with an ELISA-style approach. Click chemistry is a proprietary development of the Scripps Research Institute.

"There has not been a simple screen until now,” said senior author Dr. Kim D. Janda, professor of chemistry and immunology at the Scripps Research Institute. Dr. Janda and his research associate Dr. Amanda Garner reported in the September 15, 2010, online edition of the journal Angewandte Chemie that "This new assay technology is both highly sensitive and reproducible, making it an excellent assay for high-throughput screening.”

Related Links:
Scripps Research Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Prefilled Tubes
Prefilled 5.0ml Tubes
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.